Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCAA for Serum Albumin Improvement in Cirrhotic Patients with Ascites
NCT02755701Phase 4Unknown
- Sponsor
- Soonchunhyang University Hospital
- Start
- Jul 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of Livact in Liver cirrhosis (LC) and ascites (2 arms), sponsored by Soonchunhyang University Hospital. Primary endpoint: Change in serum albumin level at 24 weeks. Status: unknown.
02
Drugs
Livact
03
Conditions
Liver cirrhosis (LC)ascites
Beyond the preview
Go deeper on NCT02755701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755701.